Alice Yam
Vice President, Early Development & Strategic Program Management Sutro Biopharma
Alice Yam is Vice President of Early Development and Strategic Program Management at Sutro Biopharma, bringing over 20 years of biopharmaceutical R&D experience spanning protein engineering, platform innovation, and drug discovery. Her career includes progressive leadership roles at Sutro, reflecting deep expertise in engineered biologics, discovery workflows, and drug development. She began her career as a Research Fellow at Novartis Vaccines & Diagnostics and holds a PhD in Biological Sciences from Stanford University.
Seminars
Tuesday 13th October 2026
Driving Clinical Success With STRO-006: Breaking Down Insights From PDX Response & Translational Biomarkers
12:00 pm
- Outlining design and development of STRO-006, an integrin beta-6 targeted DAR8 Topo1 ADC
- Evaluating STRO-006 in a PDX clinical trial to identify biomarkers correlating with response
- Undergoing translational workstreams to enable successful clinical development
Tuesday 13th October 2026
Panel Discussion: Building the Next Generation of ADC Linkers & Payloads: What do Innovators Need from Development & Manufacturing Partners?
5:45 pm
- Discussing the scientific, technical, and strategic factors that drive ADC program success, spanning established linkers and payloads as well as emerging ADC mechanisms and designs
- Exploring how development and manufacturing partners can evolve to support the changing needs of both large pharmaceutical companies and emerging biotech organizations as ADC innovation accelerates and oncology applications expand
- Exploring evolving development and manufacturing requirements, key innovation challenges, and how partnerships can help accelerate the next generation of impactful ADC therapeutics
